Medicine and Dentistry
Psychosis
100%
Patient
72%
Association
66%
Drug Therapy
47%
Inpatient
46%
Volunteer
38%
Functional Magnetic Resonance Imaging
36%
Anterior Cingulate
33%
Clozapine
33%
Proton Nuclear Magnetic Resonance
33%
Cingulate Cortex
33%
Cost-Effectiveness Analysis
33%
Glutamic Acid
33%
Cohort Analysis
33%
Typical Antipsychotic
21%
Saturated Fatty Acid
20%
Disease
18%
Age
18%
Body Mass Index
16%
Nerve Potential
16%
Chemotherapeutic Agent
16%
Drug
16%
Obesity
15%
Chronicity
15%
Exercise
15%
Symptom
13%
Blood-Oxygen-Level Dependent
10%
Cognition
9%
Unsaturated Fatty Acid
9%
Dietary Intake
9%
Health Care Cost
8%
Case-Control Study
7%
Prevalence
7%
Hemodynamic
7%
International Physical Activity Questionnaire
7%
Life Expectancy
7%
Nutrition Education
7%
Eating
7%
Positive and Negative Syndrome Scale
6%
Man
6%
Woman
6%
Neuroscience
Psychosis
100%
Glutamic Acid
66%
Anterior Cingulate Cortex
41%
Brain
39%
Nuclear Magnetic Resonance Spectroscopy
37%
Dementia Praecox
35%
Antipsychotic
34%
Clozapine
33%
Treatment-Resistant Schizophrenia
33%
Functional Magnetic Resonance Imaging
33%
Saturated Fatty Acid
20%
Body Mass Index
16%
Nerve Potential
16%
Positive Syndrome
13%
Negative Syndrome
13%
Nucleus Accumbens
12%
Blood-Oxygen-Level Dependent
10%
Unsaturated Fatty Acid
9%
Striatum
9%
Ethnicity
9%
Caudate Nucleus
8%
Functional Magnetic Resonance Imaging
7%
Hypothalamus
6%